Vertebral Artery Stenosis Clinical Trial
Official title:
Drug-coated Balloon Angioplasty for Patients With Symptomatic Vertebral Artery Stenosis
Posterior circulation stroke accounts for 20% of ischemic stroke. A quarter occurs in patients with stenosis in the vertebral and/or basilar arteries. Vertebral artery stenosis can be treated with stenting. However, in-stent restenosis rate have been reported as high as more than 30%, which may reduce the effect of stent therapy. Drug-coated balloon has shown good results in controlling neointimal hyperplasia in the femoral and popliteal arteries.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06186024 -
A PROSPECTIVE, MULTICENTER, SINGLE-ARM TRIAL FOR THE NEW SIZES OF BRIDGE STENTS FOR VERTEBRAL ARTERY STENOSIS: Bridge-MAX
|
N/A | |
Active, not recruiting |
NCT03999983 -
Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
|
||
Completed |
NCT03201432 -
Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05644314 -
Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis
|
N/A | |
Completed |
NCT03859674 -
Firehorus Rapamycin Target Eluting Vertebral Artery Stent System in Clinical Application
|
N/A | |
Recruiting |
NCT06301776 -
A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge
|
N/A | |
Recruiting |
NCT05885932 -
Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis
|
N/A | |
Recruiting |
NCT00172458 -
Clinical Results and Restenosis Analysis of Symptomatic Ostial Vertebral Artery Stenosis Treated With Tubular Coronary Stents
|
N/A |